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Cullin3-KLHL15 ubiquitin ligase mediates CtIP
protein turnover to ﬁne-tune DNA-end resection
Lorenza P. Ferretti1, Sarah-Felicitas Himmels1, Anika Trenner1, Christina Walker1, Christine von Aesch1,
Aline Eggenschwiler1, Olga Murina1, Radoslav I. Enchev2, Matthias Peter2, Raimundo Freire3,
Antonio Porro1 & Alessandro A. Sartori1
Human CtIP is a decisive factor in DNA double-strand break repair pathway choice by
enabling DNA-end resection, the ﬁrst step that differentiates homologous recombination
(HR) from non-homologous end-joining (NHEJ). To coordinate appropriate and timely
execution of DNA-end resection, CtIP function is tightly controlled by multiple protein–
protein interactions and post-translational modiﬁcations. Here, we identify the Cullin3 E3
ligase substrate adaptor Kelch-like protein 15 (KLHL15) as a new interaction partner of CtIP
and show that KLHL15 promotes CtIP protein turnover via the ubiquitin-proteasome pathway.
A tripeptide motif (FRY) conserved across vertebrate CtIP proteins is essential for
KLHL15-binding; its mutation blocks KLHL15-dependent CtIP ubiquitination and degradation.
Consequently, DNA-end resection is strongly attenuated in cells overexpressing KLHL15 but
ampliﬁed in cells either expressing a CtIP-FRY mutant or lacking KLHL15, thus impacting the
balance between HR and NHEJ. Collectively, our ﬁndings underline the key importance and
high complexity of CtIP modulation for genome integrity.
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T
o preserve genome integrity, cells have evolved a complex
system of DNA damage detection, signalling and repair:
the DNA damage response (DDR). Following genotoxic
insults, upstream DDR factors rapidly assemble at damaged
chromatin, where they activate lesion-speciﬁc DNA repair
pathways as well as checkpoints to delay cell cycle progression,
or, if DNA repair fails, to trigger apoptosis1. DNA double-strand
breaks (DSBs) are one of the most lethal types of DNA damage
with the potential to cause genomic instability, a hallmark and
enabling characteristic of cancer2. DSBs are induced by ionizing
irradiation (IR) or frequently arise during replication when forks
collide with persistent single-strand breaks, such as those
generated by camptothecin (CPT), a DNA topoisomerase I
inhibitor3. To maintain genome stability, cells have evolved
two major pathways dealing with the repair of DSBs:
non-homologous end-joining (NHEJ) and homologous
recombination (HR)4. NHEJ is the canonical pathway during
G0/G1 phase of the cell cycle and repairs the majority of
IR-induced DSBs. In this process, broken DNA ends are religated
regardless of sequence homology, making NHEJ potentially
mutagenic5. HR, instead, is an error-free repair pathway, which
requires the presence of an undamaged homologous template,
usually the sister chromatid6. Thus, HR is restricted to S and G2
phases of the cell cycle and preferentially repairs DSBs resulting
from replication fork collapse7. The ﬁrst step of HR, termed
DNA-end resection, involves the processing of one DSB end to
generate 30single-stranded DNA (ssDNA) tails that, after being
coated by the Rad51 recombinase, mediate homology search and
invasion into the sister chromatid strand. DNA-end resection is
initiated by the combined action of the MRE11–RAD50–NBS1
(MRN) complex and CtIP8, and is a key determinant of DSB
repair pathway choice, as it commits cells to HR by preventing
NHEJ9.
The ubiquitination and neddylation machineries have recently
emerged as a crucial players for maintaining genome stability by
orchestrating key DDR events including various DNA repair
pathways10,11. Ubiquitination of target proteins involves the
concerted action of three factors: E1 ubiquitin-activating
enzymes, E2 ubiquitin-conjugating enzymes and E3 ubiquitin
ligases, which determine substrate speciﬁcity12. Among the
estimated 4600 human E3s, Cullin-RING ligases (CRLs) are
the most prevalent class, controlling a plethora of biological
processes13,14. Although few CRLs, in particular those built up by
Cullin1 (also called SCF complex) and Cullin4, were shown to
function in cell cycle checkpoint control and nucleotide excision
repair15, a role for CRLs in the regulation of DSB repair has so far
remained largely elusive.
Here, we identify the human Kelch-like protein 15 (KLHL15),
a substrate-speciﬁc adaptor for Cullin3 (CUL3)-based E3
ubiquitin ligases, as a novel CtIP interaction partner.
We show that CUL3-KLHL15 catalyses polyubiquitination and
proteasome-dependent degradation of CtIP. Mechanistically,
we ﬁnd that KLHL15 recognizes a short-tripeptide motif (FRY)
located in the conserved C-terminal domain (CTD) of CtIP and
that mutation of this motif protects CtIP from KLHL15-
dependent degradation resulting in prolonged CtIP protein
half-life and, consequently, excessive DNA-end resection.
We further demonstrate that cells lacking KLHL15 phenocopy
the behaviour of FRY mutant cells, including reduced
NHEJ efﬁciency as a consequence of CtIP protein accumulation
and increased resection. Finally, we provide evidence that
PIN1-dependent isomerization of CtIP facilitates its targeting
by CUL3-KLHL15. Taken together, our results uncover
a critical role for CUL3-KLHL15 ubiquitin ligase in governing
CtIP DNA-end resection activity and DSB repair pathway
choice.
Results
CtIP interacts with the CUL3 substrate adaptor KLHL15. To
gain further insights into the regulation of DNA-end resection in
human cells, we searched for novel interacting partners of CtIP by
tandem afﬁnity puriﬁcation followed by mass spectrometry. To
this end, we generated a stable HEK293 cell line inducibly
expressing Strep-HA-tagged CtIP. To reduce the number of false
positive protein–protein interactions, we used a tetracycline
concentration (10 ngml 1) at which the expression levels were
comparable to those of endogenous CtIP (Supplementary Fig. 1a).
Remarkably, besides the CtIP bait protein, only two proteins were
identiﬁed with multiple peptides in two independent mass
spectrometry analyses, Kelch-like protein 15 (KLHL15) and
Cullin3 (CUL3) (Fig. 1a; and Supplementary Fig. 1b). KLHL15
belongs to a family of 42 human proteins that possess an
N-terminal BTB-BACK domain and a C-terminal Kelch domain
comprising ﬁve to six Kelch repeats16. Kelch-like proteins
bind CUL3 through their BTB-BACK domain, whereas
substrate recognition is mediated by the Kelch domain17–19.
Importantly, many Kelch-like proteins function as substrate-
speciﬁc adaptors in CUL3-based E3 ligase complexes to
catalyse protein ubiquitination and degradation by the 26S
proteasome20.
To conﬁrm the result of our proteomic analysis, suggesting that
CtIP and CUL3-KLHL15 form a complex, we ﬁrst performed
an immunoprecipitation (IP) experiment and found that
endogenous KLHL15 and CUL3 efﬁciently co-precipitated with
GFP-tagged CtIP (Fig. 1b). Similarly, endogenous CtIP was
successfully recovered following co-IP of FLAG-tagged KLHL15,
but was not present in co-immunocomplexes containing CUL3
and KLHL22 (Supplementary Fig. 1c), which is the closest
ortholog of KLHL15 (refs 18,21). Next, we generated two
FLAG-KLHL15 truncation mutants lacking either the Kelch
(DKelch) or the BTB-BACK (DBþB) domain (Fig. 1c,d). As
expected, CUL3-KLHL15 interaction was largely abolished in the
DBþB mutant, whereas CtIP binding to KLHL15 was strongly
impaired in the DKelch mutant (Fig. 1d). Interestingly, we
observed that direct interactions between the individual KLHL15
domains and CUL3 or CtIP were weakened in both truncation
mutants, indicating that the structural integrity of full-length
KLHL15 is important for stable ternary complex formation
between CtIP, KLHL15 and CUL3 (Fig. 1d). In case of the DBþB
mutant, this could in part be explained by the fact that the
BTB adaptor domain was shown to be required for the
efﬁcient dimerization and activation of CUL3 ubiquitin ligase
complexes18,22,23. To identify speciﬁc amino acid residues in
KLHL15 that mediate binding to CUL3, we performed multiple
sequence alignments of various human BTB-Kelch proteins and
the MATH-BTB protein SPOP. This revealed the presence of a
conserved, paired helix structure following the BTB domain of
KLHL15, which is predicted to constitute a CUL3-interacting box
(3-box) (Fig. 1c and Supplementary Fig. 1d)23. Similar to what we
observed for the DBþB truncation mutant, substituting either
asparagine 132 or isoleucine 136 for alanine (N132A and I136A,
respectively) in the 3-box of full-length FLAG-KLHL15 decreased
its interaction with CUL3, especially with the neddylated form of
CUL3 (Fig. 1c,e). Neddylation, the covalent attachment of the
small ubiquitin-like protein NEDD8 to proteins, has been
demonstrated to be essential for the activation of most
cullin-based E3 ligases13,24. Next, through sequence alignments
of the Kelch domain of human and zebraﬁsh KLHL15 with the
respective Keap1 (alias KLHL19) homologues, we located glycine
386 in the third repeat (G386) and tyrosine 552 (Y552) in
the sixth repeat (Fig. 1c and Supplementary Fig. 1e). Importantly,
mutation of these residues in Keap1 disrupted its ability to bind
Nrf2 and repress Nrf2-dependent transcription25,26. Consistently,
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12628
2 NATURE COMMUNICATIONS | 7:12628 | DOI: 10.1038/ncomms12628 | www.nature.com/naturecommunications
we observed that KLHL15-G386C and -Y552A mutants were
defective in CtIP binding (Fig. 1c,f).
In the course of these experiments, we noticed that endogenous
CtIP protein levels were differentially altered in cells transfected
with KLHL15 expression constructs with a marked decrease
in presence of wild-type (wt) KLHL15 (Fig. 1d–f). To further
address this issue, we measured CtIP protein stability using a
cycloheximide (CHX) chase assay and found that CtIP shows a
decreased protein half-life and is more rapidly degraded in cells
overexpressing KLHL15-wt than in cells transfected with
KLHL15-Y552A mutant (Supplementary Fig. 1f). Taken together,
these results demonstrated that CUL3-KLHL15 speciﬁcally
interacts with CtIP and controls its protein turnover.
CRL3KLHL15 ubiquitin ligase targets CtIP for degradation.
To conﬁrm our above results, using a different cell system, we
generated stable U2OS cells expressing doxycycline (Dox)-
inducible GFP-tagged KLHL15. As shown in Fig. 2a, we detected
a signiﬁcant decrease of endogenous CtIP protein levels already at
24 h following induction of KLHL15 expression and found that
this was partially restored by addition of the proteasome inhibitor
MG-132. Similarly, treatment of KLHL15-induced cells with
MLN-4924, a small molecule inhibitor of the NEDD8-activating
enzyme27, greatly increased CtIP protein stability, indicating that
CtIP degradation by KLHL15 requires CUL3 activation (Fig. 2b).
Speciﬁcally, our results indicated that CUL3 acts together with
KLHL15 in promoting CtIP degradation, as its downregulation
stabilized CtIP in cells overexpressing KLHL15 (Fig. 2c).
Consistently, transfection of three siRNA oligos targeting
different regions in the KLHL15 transcript reproducibly
increased CtIP protein levels in parental U2OS cells (Fig. 2d
and Supplementary Fig. 2a); without affecting cell cycle
distribution (Supplementary Fig. 2b). Of note, we only detected
a robust KLHL15 protein signal in the chromatin-enriched
fraction, suggesting a role for KLHL15 in targeting substrates
predominantly in the nucleus (Fig. 2d). Furthermore, using stable
U2OSGFP-KLHL15 cells, siRNA oligos targeting the coding
sequence of KLHL15 (#1 and #2) efﬁciently depleted exogenous
KLHL15, thereby restoring CtIP protein levels (Fig. 2e). In
contrast, CtIP was still degraded upon induction of GFP-KLHL15
in cells transfected with siRNA against the 30-untranslated region
of KLHL15 (#3) speciﬁcally silencing endogenously expressed
KLHL15 (Fig. 2e). Consistent with a key function of KLHL15 in
regulating CtIP protein turnover, we observed that the half-life
of CtIP was prolonged after KLHL15 downregulation
(Supplementary Fig. 2c).
Proteasome-dependent proteolysis typically requires the con-
jugation of ubiquitin to the target protein. Therefore, we next
addressed whether KLHL15 mediates CtIP ubiquitination in vivo.
To this end, we transfected HEK293 cells inducibly expressing
GFP-CtIP with histidine-tagged ubiquitin and analysed the level
of CtIP ubiquitination after Ni-NTA pull-down under denaturing
conditions. As previously reported28,29, we readily detected
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Figure 1 | CtIP interacts with the CUL3-KLHL15 complex. (a) HEK293 cells inducibly expressing StrepHA-tagged CtIP were used for tandem afﬁnity
puriﬁcation of protein complexes. The number of unique peptides and sequence coverage for the proteins identiﬁed by mass spectrometry are listed.
‘/’ delimitates the data from two biological replicates. (b) HEK293T cells were transfected with either empty vector (EV) or the GFP-CtIP expression
constructs. Forty-eight hours after transfection, cells were lysed and whole-cell extracts were subjected to IP using anti-GFP afﬁnity resin. Inputs and
recovered protein complexes were analysed by immunoblotting. (c) Schematic representation of the human KLHL15 protein indicating truncation and
single-amino acid point mutants thereof used in d–f. ‘3-box’ denotes CUL3-interacting box, whereas the six Kelch repeats are indicated in pink.
(d–f) HEK293T cells were transfected with either EV or the indicated FLAG-KLHL15 expression constructs. Forty-eight hours after transfection, cells were
lysed and whole-cell extracts were subjected to IP using anti-FLAG M2 afﬁnity resin. Inputs and recovered protein complexes were analysed by
immunoblotting. Asterisks indicate neddylated CUL3.
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polyubiquitinated species of CtIP upon MG-132 treatment
(Fig. 2f). In contrast, however, CtIP ubiquitination was severely
impaired in KLHL15- or CUL3-depleted cells (Fig. 2f). To prove
that the CUL3-KLHL15 E3 ligase complex is sufﬁcient to catalyse
CtIP ubiquitination in vitro, we expressed and puriﬁed
recombinant FLAG-CtIP and MBP-KLHL15 from HEK293T
and Sf9 insect cells, respectively (Supplementary Fig. 2d).
Recombinant CUL3/RBX1 was neddylated in vitro using the
puriﬁed NEDD8 (N8) conjugation system30. Next, CtIP and
KLHL15 were mixed with CUL3-N8/RBX1 complex and
incubated with ATP, ubiquitin, E1 (UBE1) and E2 (Cdc34 or
UbcH5b) enzymes. Western blot analysis revealed that CtIP was
extensively modiﬁed when all components of the ubiquitination
machinery were present in the reaction (Fig. 2g). Moreover, we
found that this reaction was speciﬁcally catalysed by KLHL15
in vitro, since CtIP ubiquitination was not supported by KLHL21
(Supplementary Fig. 2e, lanes 11–13). As it is well-established
that proteins targeted for proteasomal degradation are often
conjugated to lysine 48 (K48) linked ubiquitin chains,
we compared the efﬁciency of CtIP polyubiquitination by
CUL3-KLHL15 between K48-only and K48R ubiquitin mutants
using the same assay. We observed that CtIP ubiquitination was
almost completely abrogated in presence of the K48R mutant,
whereas chain formation was indistinguishable between wild-type
and K48-only ubiquitin (Supplementary Fig. 2e). Collectively, our
results demonstrated that CUL3-KLHL15 promotes K48-linked
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Figure 2 | CUL3-KLHL15 E3 ligase promotes CtIP protein turnover via the ubiquitin-proteasome pathway. (a) U2OS Flp-In T-REx cells stably expressing
doxycycline (Dox)-inducible GFP-KLHL15-wt were cultivated in the absence ( ) or presence (þ ) of Dox. Twenty-four hours post induction, cells were
either mock-treated or treated with MG-132 (10 mM) for 6 h and whole-cell lysates were analysed by immunoblotting. (b) Twenty-four hours post
induction, same cells as in a were either mock-treated or treated with MLN-4924 (100 nM) for 8 h and whole-cell lysates were analysed by
immunoblotting. (c) Same cells as in a were transfected with either non-targeting (CNTL) or CUL3 siRNA oligos. 48 h later, GFP-KLHL15 expression was
induced with Dox for 24 h and whole-cell lysates were analysed by immunoblotting. (d) U2OS cells were transfected with the indicated siRNA oligos for
48 h. Total cell extracts and chromatin-enriched fractions were analysed by immunoblotting using the indicated antibodies. (e) Same cells as in a were
transfected with the indicated siRNA oligos. Twenty-four hours post transfection, cells were grown for 24 h in the absence ( ) or presence (þ ) of Dox
and whole-cell lysates were analysed by immunoblotting. (f) HEK293 Flp-In T-REx cells inducibly expressing GFP-CtIP were transfected with the indicated
siRNAs. Forty-eight hours later, cells were transfected with His-Ub and the expression of CtIP was simultaneously induced with Dox. Eight hours post
induction, cells were transfected with siRNAs for a second time. Three days after the ﬁrst siRNA transfection, cells were treated with MG-132 (20mM) for
6 h followed by lysis in buffer containing guanidium-HCl. Ubiquitin conjugates were pulled-down (PD) with Ni-NTA-agarose beads, eluted and analysed by
immunoblotting with anti-GFP antibody. (g) Recombinant FLAG-CtIP was incubated with ATP, ubiquitin, E1, E2 enzymes and CUL3-N8/RBX1-KLHL15 (E3)
for 30min at 37 C. Unmodiﬁed and ubiquitinated CtIP protein species were detected by immunoblotting with anti-FLAG antibody. Asterisks indicate
neddylated CUL3.
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CtIP polyubiquitination leading to its proteasome-dependent
degradation.
CtIP protein accumulates in KLHL15 knockout cells. Since
HEK293 cells were used in our proteomics screen for proteins
that interact with CtIP, we rationalized that KLHL15 is
adequately expressed in this cell line. Thus, we generated stable
HEK293 KLHL15 knockout cells (HEK293Cas9/KLHL15D) using
the CRISPR method introduced by Munoz et al.31 We ﬁrst
screened several, single-cell clones for Cas9-induced disruption
of KLHL15 protein by western blotting performed with a
homemade rabbit polyclonal antibody raised against a
recombinant fragment (amino acids 300–604) of human
KLHL15 (Fig. 3a). Remarkably, and consistent with our
previous ﬁndings, we observed a perfect positive correlation
between the absence of KLHL15 and increase of CtIP protein
levels (Fig. 3a). To further prove that the KLHL15 gene was
efﬁciently knocked out, the CRISPR-targeted genomic locus in
HEK293Cas9/KLHL15D clone 1 was PCR-ampliﬁed and subjected to
deep-sequencing demonstrating that biallelic KLHL15-editing
resulted in two truncated KLHL15 proteins harbouring only the
N-terminal BTB domain (Supplementary Fig. 3a,b). Consistent
with our previous data in U2OS cells (Fig. 2d), KLHL15 is
strongly associated with the chromatin compartment in HEK293
cells, further indicating that KLHL15 targets CtIP for
ubiquitination and degradation in the nucleus (Fig. 3b).
Notably, we found that KLHL15 loss does not affect cell cycle
progression and, vice versa, that KLHL15 is expressed throughout
the cell cycle (Supplementary Fig. 3c,d). Finally, we observed that
CtIP protein half-life was dramatically prolonged in KLHL15
knockout cells and that MG-132 treatment did not alter CtIP
protein stability in those cells, further supporting the importance
of KLHL15 in governing CtIP protein turnover (Fig. 3c).
KLHL15 expression sensitizes cells to CPT by inhibiting resection.
To investigate the role of KLHL15 in the DDR, we generated
U2OS clones inducibly expressing GFP-tagged KLHL15-G386C
and -Y552A, two mutants defective in CtIP binding (see Fig. 1f).
However, in contrast to KLHL15-wt and KLHL15-Y552A, which
localized predominantly in the nucleus and were present in the
chromatin-enriched fraction, KLHL15-G386C was exclusively
cytoplasmic and therefore excluded from further studies
(Supplementary Fig. 4a,b). Consistent with our previous ﬁndings,
CtIP protein levels were reduced in KLHL15-wt compared with
KLHL15-Y552A mutant cells already at 24 h following induction
of KLHL15 expression (Supplementary Fig. 4b).
In S and G2 phases of the cell cycle, CtIP is required for the
processing of DSBs into ssDNA, triggering HR. Consequently,
CtIP-deﬁcient cells display reduced DNA-end resection and
hypersensitivity towards CPT, a DNA topoisomerase inhibitor
causing DSBs speciﬁcally at the replication fork8. In large
agreement with that, we found that cells overexpressing
KLHL15-wt, therefore harbouring very little amounts of CtIP,
were hypersensitive to CPT (Fig. 4a). In response to DSBs, CtIP is
required for RPA2 hyperphosphorylation, a commonly accepted
marker for DNA-end resection32. Strikingly, the level of
phosphorylated RPA2 upon CPT treatment was signiﬁcantly
reduced in KLHL15-wt compared with KLHL15-Y552A mutant
cells (Fig. 4b and Supplementary Fig. 4c). Next, using a recently
established ﬂow-cytometry-based method to detect RPA retention
on damaged chromatin33, we observed that the percentage of
CPT-induced RPA-positive cells was speciﬁcally reduced upon
induction of KLHL15-wt expression (Fig. 4c), indicative of
DNA-end resection defect. To directly measure the formation of
ssDNA in response to CPT treatment, we employed the same
approach but instead immunostained bromodeoxyuridine
(BrdU)-labelled cells with an anti-BrdU antibody. Consistently,
the BrdU signal was dramatically reduced in cells overexpressing
KLHL15-wt, but not in the Y552A mutant cells (Fig. 4c).
Importantly, the reported cellular phenotypes caused by
KLHL15-wt overexpression were generally milder but followed
the same trend as those caused by CtIP downregulation
(Supplementary Fig. 4d–f). On the basis of these ﬁndings, we
analysed the effect of KLHL15 expression on the efﬁciency of
DSB repair by HR in established reporter cells34. As expected,
transient transfection of these cells with KLHL15-wt, but not with
KLHL15-Y552A, resulted in a signiﬁcant reduction in HR
frequency compared with control cells (Fig. 4d). Taken
together, our data suggest that KLHL15 overexpression is
detrimental to DNA-end resection and HR, most likely caused
by enhanced CtIP proteasomal degradation.
The C-terminal domain of CtIP mediates binding to KLHL15.
To gain further insights into the mechanism by which KLHL15
promotes CtIP protein turnover, we sought to identify the region
within CtIP responsible for KLHL15 interaction. Human CtIP has
two recognizable domains (Fig. 5a), a coiled-coil domain35 and a
highly conserved Sae2/Ctp1-like CTD, which is required for
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Figure 3 | CtIP protein turnover is impaired in KLHL15 knockout cells.
(a) Lysates from a stable HEK293Cas9 wild-type (wt) cell clone or from six
different HEK293Cas9 cell clones generated with the same sgRNA targeting
KLHL15 (see Supplementary Fig. 3a) were subjected to western blotting
with the indicated antibodies. (b) Total (T) cell extracts and chromatin-
enriched (Chr.) fractions of HEK293Cas9/wt and HEK293Cas9/KLHL15D cells
were analysed by immunoblotting using the indicated antibodies. (c) Same
cells as in b were either mock-treated, treated with CHX (100mgml 1) or
MG-132 (20 mM) for the indicated time points and lysates were subjected
to western blotting with the indicated antibodies (upper panel). SE and LE;
short- and long-exposure times of the same immunoblot. Relative CtIP
protein levels were determined by quantiﬁcation of CtIP band intensity
(normalized to TFIIH) with the ImageJ software (lower panels). Data are
represented as mean values of densitometric quantiﬁcation±s.e.m. (n¼ 3).
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DNA-end resection8. In addition, CtIP contains several short
sequence motifs (Fig. 5a) that are important for CtIP
tetramerization36–38 or for physical interactions with other
proteins, such as FANCD2 (ref. 39), PIN1 (ref. 28), BRCA1
(refs 40,41) and CDH1 (ref. 42). Interestingly, by performing
MBP-KLHL15 pull-down experiments from HEK293T cell lysates
expressing different CtIP constructs, we found that GFP-CtIP-wt
and GFP-CtIP-DN (deleted of amino acids (aa) 153–322)
interacted with KLHL15, whereas GFP-CtIP-DC1 lacking the
entire CTD (aa 790–897) did not (Fig. 5b). Moreover, when the
same constructs were cotransfected with FLAG-KLHL15 into
HEK293T cells, quantiﬁcation of protein levels revealed that
CtIP-DN showed rather variable abundance, whereas CtIP-DC1
was resistant to KLHL15 overexpression (Supplementary Fig. 5a).
In fact, increased protein stability of a C-terminally truncated
form of CtIP has been reported previously43. Consistently, we
observed that ubiquitination of CtIP-DC1 in vivo (Fig. 5c) and
in vitro (Supplementary Fig. 5b) was decreased compared with
CtIP-wt. These results indicated that the CTD in CtIP is required
for KLHL15 binding and subsequent ubiquitin-dependent
proteolysis of CtIP.
To narrow down our search for a putative KLHL15-interaction
motif in CtIP, we generated two additional CtIP C-terminal
truncation mutants. Interestingly, GFP-CtIP-DC3 (aa 1–863) was
still efﬁciently pulled-down and degraded by KLHL15, whereas
GFP-CtIP-DC2 (aa 1–812) was not, suggesting that KLHL15
binds to a small region in the CTD of CtIP encompassing residues
813–863 (Fig. 5d and Supplementary Fig. 5c). In addition, by
using pull-down assays, we found that a synthetic 15-mer peptide
consisting of CtIP residues 830–844 (Fig. 5a) strongly interacted
with GFP-KLHL15 expressed in cells as well as with endogenous
KLHL15 in pull-down assay (Fig. 5e,f). Remarkably, the short
peptide was effective in outcompeting the binding of endogenous
CtIP to MBP-KLHL15, indicating that its amino acid sequence
contained key residues required for KLHL15 interaction (Fig. 5g).
Tyrosine residue 842 of CtIP is essential for KLHL15 binding.
To date, the protein phosphatase 2A (PP2A) regulatory subunit
B0-beta is the only described substrate for the CUL3-KLHL15 E3
ubiquitin ligase44. This study established a tyrosine residue within
a conserved stretch of three amino acids (FRY) as being critically
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important for KLHL15-mediated degradation of PP2A/B0-beta.
Strikingly, when we looked for the presence of a similar motif in
human CtIP, sequence alignments highlighted a well-conserved
FRY motif (aa 840–842) located exactly within the region
previously shown to mediate KLHL15 interaction (Fig. 6a). Of
note, CtIP homologues in Caenorhabditis elegans, Dictyostelium
discoideum and Schizosaccharomyces pombe did not contain a
FRY motif at this position (Fig. 6a), which could be partly
explained by the fact that BTB-BACK-Kelch family proteins are
extremely rare in worms and completely absent in slime molds
and yeast45.
To investigate whether the CtIP FRY motif is involved
in KLHL15 recognition, we ﬁrst generated a triple-alanine
substitution mutant (GFP-CtIP-AAA) and observed that the
protein was partially resistant to KLHL15-mediated degradation
(Supplementary Fig. 6a). Next, we focused on elucidating the role
of Y842 in being the prime determinant for the physical
interaction between CtIP and KLHL15, as shown for Y52 in
PP2A/B0-beta44. Indeed, pull-down assays using bacterially
expressed GST-CtIP-CTD as bait showed that the replacement
of tyrosine 842 with alanine (Y842A) severely impaired binding
of the CUL3-KLHL15 complex (Fig. 6b), whereas the previously
established interaction with MRE11 (refs 8,46,47) remained
largely unaffected (Supplementary Fig. 6b,c). Next, we subjected
cell lysates expressing GFP-CtIP to IP using GFP antibody beads
and found that the Y842A mutant exhibited reduced binding to
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endogenous KLHL15 and CUL3 as compared with wild-type
protein (Fig. 6c). Likewise, MBP-pull-down assays showed
decreased interaction between KLHL15 and CtIP-Y842A
(Fig. 6d). Importantly, using the same approach, we found that
replacing Y842 with a non-phosphorylatable phenylalanine
completely restored KLHL15-CtIP interaction (Fig. 6d),
indicating that Y842 phosphorylation is not required for
KLHL15 binding, whereas the side-chain aromatic ring at this
position is. As a functional consequence of reduced KLHL15
interaction, we observed that the CtIP-Y842A mutant was
partially defective in polyubiquitination in vivo (Fig. 6e).
Consistent with these ﬁndings, CtIP-Y842A was resistant to
KLHL15 overexpression, whereas CtIP-Y842F was degraded to
the same extent as CtIP-wt (Fig. 6f). To examine whether the FRY
motif indeed constitutes a canonical docking site for KLHL15, we
constructed two additional CtIP mutants in which F840 and
R839, located in the conserved neighbouring ’RHR’ motif,
were also substituted with alanine residues (Fig. 6a). We again
cotransfected the GFP-tagged versions together with FLAG-
KLHL15 and found that F840A behaved identical to Y842A in
terms of being resistant to KLHL15 overexpression, whereas
R839A was degraded to a similar extent as compare to wild-type
(Fig. 6f). Taken together, these ﬁndings indicate that the FRY
motif and Y842 in particular are essential for KLHL15
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recognition and subsequent degradation of CtIP by the ubiquitin-
proteasome pathway.
KLHL15 regulates DNA-end resection and DSB repair. To
investigate the role of CtIP ubiquitination by KLHL15 in response
to DNA damage, we generated stable U2OS cell clones inducibly
expressing siRNA-resistant GFP-tagged CtIP-wt or CtIP-Y842A.
Importantly, cell cycle proﬁles, CtIP nuclear localization and
accumulation to DSB-containing tracks generated by laser
microirradiation were highly similar in both cell lines, indicating
that these transgenes are functional (Supplementary Fig. 7a–c).
Interestingly, cycloheximide chase experiments revealed that
CtIP-Y842A had a much prolonged half-life compared with
CtIP-wt, a phenotype reminiscent of the reduced CtIP protein
turnover in KLHL15 knockout cells (Supplementary Fig. 7d).
However, CtIP-Y842A efﬁciently rescued CPT hypersensitivity of
CtIP-depleted cells, suggesting that increased CtIP protein
stability does not negatively affect CtIP function in DSB proces-
sing (Supplementary Fig. 7e). Next, we compared CPT-induced
ATM/ATR activation between the two cell lines by western
blotting to assess whether impairment of KLHL15 binding to
CtIP has an impact on DNA damage signalling. Interestingly, we
found that ATR-mediated CHK1 and RPA2 phosphorylation was
increased in CtIP-Y842A mutant compared with CtIP-wt cells,
indicative of elevated DNA-end resection, whereas ATM
autophosphorylation remained unaltered (Fig. 7a). Moreover,
Y842A rescued defective RPA2 hyperphosphorylation in
CtIP-depleted cells to a much higher extent as compared with
control cells (Fig. 7b). Next, we analysed RPA accumulation on
damaged chromatin as well as the formation of ssDNA by
ﬂow-cytometry. Consistent with our immunoblot analysis, Y842A
led to increased RPA chromatinization and ssDNA formation
upon CPT treatment, further demonstrating that impaired CtIP
protein turnover causes hyper-resection of DSBs (Fig. 7c).
Underscoring the importance of KLHL15 in regulating DNA-end
resection, we observed that KLHL15 knockout cells display
elevated RPA2 phosphorylation levels as compared with control
cells (Fig. 7d). Importantly, siRNA-mediated downregulation of
CtIP in KLHL15 knockout cells suppressed the hyper-resection
phenotype (Fig. 7d), indicating that KLHL15 limits resection by
promoting CtIP proteasomal degradation and that CtIP is most
likely the key substrate of KLHL15 involved in the DDR. Next,
using the ﬂow-cytometry-based assay to quantify DNA-end
resection, we observed that the amount of RPA-bound ssDNA in
KLHL15 knockout cells was far higher than in control cells
(Fig. 7e). Furthermore, loss of KLHL15 resulted in a marked
increase of RPA2 hyperphosphorylation after treatment with
ionizing radiation (IR) (Fig. 7f). DNA-end resection is inhibitory
to the repair of DSBs by NHEJ. With regards to this view and
since NHEJ is the predominant repair mechanism for IR-induced
two-ended DSBs, we next addressed the survival of KLHL15
knockout cells following IR treatment using clonogenic assay.
Remarkably, HEK293Cas9/KLHL15Dcells were hypersensitive to IR,
indicative of compromised NHEJ activity (Fig. 7g). To investigate
whether regulation of CtIP protein turnover by KLHL15 plays a
direct role in DSB repair pathway choice, we measured NHEJ or
HR frequencies in HEK293 GFP-reporter cells34. First, we
discovered that KLHL15 knockdown caused a signiﬁcant
reduction in NHEJ, similar to that seen after depletion of the
canonical NHEJ factor XRCC4 (Fig. 7h). In large agreement with
this ﬁnding, NHEJ frequency was decreased upon overexpression
the CtIP-Y842A mutant, further supporting the concept that
excessive DNA-end resection is counterproductive for NHEJ
(Supplementary Fig. 7f). Next, we performed HR reporter assays
and observed that downregulation of KLHL15 coincided with
increased HR efﬁciency (Fig. 7i), whereas CtIP-Y842A had no
major impact on homology-directed repair of DSBs
(Supplementary Fig. 7g). Altogether, this data provide evidence
that KLHL15 is a key factor governing DNA-end resection and
DSB repair pathway choice through regulating CtIP
ubiquitination and, ultimately, CtIP protein turnover.
PIN1 and KLHL15 cooperate in promoting CtIP degradation.
In an earlier study, we have reported that PIN1,
a phosphorylation-speciﬁc prolyl isomerase, promotes CtIP
degradation by the ubiquitin-proteasome pathway28. However,
the responsible E3 ligase working in concert with PIN1 in CtIP
ubiquitination has not been identiﬁed yet. Speciﬁcally, we
demonstrated that disruption of this regulatory function by
PIN1 depletion or expression of a CtIP mutant refractory to PIN1
binding resulted in hyper-resection and reduced NHEJ,
meanwhile PIN1 overexpression suppressed resection and HR.
As these cellular phenotypes are highly reminiscent of those
observed in this study, we speculated whether CtIP isomerization
by PIN1 may facilitate KLHL15-dependent CtIP degradation.
Interestingly, we found that CtIP S276A/T315A (2A) impaired in
PIN1 binding28 was partially resistant to KLHL15 overexpression
(Fig. 8a). In contrast, the CtIP KEN-box mutant (K467A)
defective in CDH1 binding and subsequent polyubiquitination by
the APC/CCdh1 E3 ligase29, was as efﬁciently degraded by
KLHL15 as the wild-type CtIP protein (Fig. 8a). This result
indicated a possible functional connection between PIN1 and
KLHL15 in controlling CtIP protein turnover. To address this
further, we next investigated whether CtIP isomerization by PIN1
may foster CtIP-KLHL15 interaction. MBP-pull-down assays
revealed that the GFP-CtIP-2A mutant protein was fully
proﬁcient in binding to recombinant KLHL15 puriﬁed from
insect cells (Supplementary Fig. 8a). Interestingly, however,
KLHL15-CtIP interaction was reduced in cells depleted for
PIN1 (Fig. 8b), indicating that isomerization of CtIP is not
essential for physical interaction between KLHL15 and CtIP,
yet that it somehow aids the formation of a ternary
CUL3-KLHL15-CtIP complex in cells. Consistent with this
hypothesis, simultaneous downregulation of KLHL15 and
PIN1 did not further reduce CtIP ubiquitination when
compared with the single knockdowns (Supplementary Fig. 8b).
As reported previously28, PIN1 overexpression destabilized CtIP
particularly in response to DSBs causing reduced RPA2
hyperphosphorylation (Fig. 8c, lanes 1–4). We now observed
that both phenotypes can be reversed by transfecting PIN1 into
KLHL15 knockout cells, indicating that PIN1-mediated CtIP
degradation after DNA damage requires KLHL15 (Fig. 8c,
lanes 5–8). Taken together, these experiments suggested that the
PIN1 isomerase, at least in certain scenarios, facilitates CtIP
ubiquitination and proteasomal degradation through the
CUL3-KLHL15 E3 ligase.
Discussion
Ubiquitination and its crosstalk with other post-translational
modiﬁcations have recently emerged as key regulatory mechan-
isms in the cellular response to DNA damage48,49. As a
consequence, defects in the ubiquitination machinery have been
shown to be associated with reduced cellular survival and
increased genomic instability in response to DSBs, mainly due
to impaired protein–protein interactions causing mislocalization
of DSB repair factors50–52. Of note, these processes mostly
involve non-proteasomal ubiquitin signalling instead of the
classical function of E3 ubiquitin ligases in targeting substrates
to proteasome-dependent degradation.
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GFP-CtIP expression was induced for 24 h and cells were treated with CPT for 1 h before western blot analysis. (c) Same cells as in b were simultaneously
labelled with BrdU (30mM). 48 h post siRNA-transfection, cells were treated with CPT for 1 h, immunostained with anti-RPA2 or anti-BrdU antibody and
analysed by FACS. Dot plots represent the intensity of the signals for RPA2 or BrdU staining (y axis) against the DNA content (x axis). Quantiﬁcation gates
were established in untreated samples and the percentage of cells within the gates are indicated. (d) HEK293Cas9/wt and HEK293Cas9/KLHL15D cells were
transfected with the indicated siRNA oligos. Forty-eight hours later, cells were treated with CPT for 1 h and analysed by immunoblotting. (e) Same cells as in
d were processed for FACS analysis as in c. (f) Same cells as in d were irradiated at 10Gy and 3 h later analysed by immunoblotting. SE and LE denote
short and long exposures of the same membrane. (g) Same cells as in d were irradiated with increasing doses of IR and survival was determined by
colony-formation assay. Data are presented as the mean±s.d. (n¼4). (h,i) HEK293 EJ5-GFP or DR-GFP cells were transfected with the indicated siRNAs.
Two days later, cells were transfected with the I-SceI expression plasmid and harvested after 48 h for ﬂow cytometry and immunoblot analysis. Data in
h and i are represented as mean±s.e.m. (n¼ 3) and as mean±s.d. (n¼4), respectively. Unpaired, two-tailed t-tests were performed and P values
expressed as *(Po0.05) and **(Po0.005) were considered signiﬁcant. Asterisks indicate hyperphosphorylated forms of CtIP and RPA2. A.u., arbitrary
units; FACS, ﬂuorescence-activated cell sorting.
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Here, we demonstrate that proteasomal degradation triggered
by a CRL3 E3 ligase plays a prominent role in the regulation of
DSB repair. Speciﬁcally, our results indicate that the BTB-BACK-
Kelch protein KLHL15 acts as an adaptor for CUL3 to target the
DNA-end resection factor CtIP for ubiquitination and subsequent
proteasomal degradation (Fig. 9). We further deﬁne the molecular
basis of the CUL3-KLHL15-CtIP ternary complex by showing
that KLHL15 interacts with CUL3 via its canonical ‘3-box’ motif
and recruits CtIP to CUL3 via its C-terminal Kelch domain.
Moreover, our data reveals that the FRY tripeptide sequence,
present in the C-terminus of CtIP, may serve as general KLHL15
docking motifs present in substrate proteins targeted by the
CUL3-KLHL15 E3 ubiquitin ligase. Speciﬁcally, we report that
CtIP-Y842, located within a conserved ‘FRY motif’, is essential
for KLHL15-mediated CtIP ubiquitination and subsequent
degradation.
CtIP is required for DNA-end resection, the initial step of
homology-directed repair, and is therefore a key factor in
controlling repair pathway choice as processed DSB ends can
no longer serve as substrates for NHEJ53. Collectively, our
ﬁndings support a model in which the CUL3-KLHL15 ubiquitin
ligase governs the turnover of CtIP to ﬁne-tune the balance
between HR and NHEJ (Fig. 9). Accordingly, cells that express
high levels of KLHL15 exhibit unscheduled and enhanced CtIP
degradation, ultimately leading to strong defects in DNA-end
resection and increased channelling of DSB repair from error-free
HR into error-prone NHEJ (Fig. 9). In contrast, cells either
lacking KLHL15 or expressing a mutant of CtIP refractory to
KLHL15 binding display aberrant accumulation of CtIP and
excessive DNA-end resection, thereby suppressing DSB repair by
NHEJ (Fig. 9). Recently, a similar regulatory function in DSB
repair has been proposed for Keap1, another CUL3 substrate
adaptor. However, rather than involving the proteasome, the
authors of this study showed that Keap1-dependent
ubiquitination of PALB2 suppresses its interaction with BRCA1,
thereby prohibiting HR in G1 cells54.
Previously, we reported that PIN1 isomerase tips the balance
between HR and NHEJ by a very similar mechanism involving
CtIP ubiquitination and degradation28. Here, we provide
circumstantial evidence that CUL3-KLHL15 is the responsible
E3 ligase operating in conjunction with PIN1 to control CtIP
protein turnover. Interestingly, we ﬁnd that isomerization of CtIP
is not essential for the direct physical interaction between
CtIP and KLHL15, but that PIN1 is important for stable
complex formation of CUL3-KLHL15-CtIP, thereby reinforcing
CtIP polyubiquitination and degradation in speciﬁc cellular
contexts. For instance, as PIN1 binding to CtIP requires initial
phosphorylation of CtIP by proline-directed kinases (for example,
cyclin-dependent kinases), we previously proposed that PIN1
triggers CtIP ubiquitination and degradation predominantly
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Figure 8 | PIN1 isomerase facilitates KLHL15-dependent degradation of CtIP. (a) HEK293T cells were cotransfected with FLAG-KLHL15 and either
GFP-CtIP-wt, -S276A/T315A (2A, defective in PIN1 interaction), or -K467A (KA, defective in Cdh1 interaction) expression constructs. Forty-eight hours
post transfection, cells were analysed by immunoblotting (left). Relative CtIP protein levels were determined by quantiﬁcation of CtIP band intensity
(normalized to Actin) with the ImageJ software (right). Data are represented as mean values of densitometric quantiﬁcation±s.e.m. (nZ3). Statistical
analysis was carried out using unpaired, two-tailed t-tests. P values expressed as *(Po0.05) was considered signiﬁcant. (b) HEK293T cells were
transfected twice with the indicated siRNA oligos for two consecutive days. Forty-eight hours after the ﬁrst siRNA transfection, cells were transfected with
either empty vector (EV) or FLAG-KLHL15 expression constructs. 72 h after the ﬁrst siRNA transfection, cells were lysed and whole-cell extracts were
subjected to IP using anti-FLAG M2 afﬁnity resin. Inputs and recovered protein complexes were analysed by immunoblotting. The asterisk indicates
neddylated CUL3. (c) HEK293Cas9/wt and HEK293Cas9/KLHL15D cells were transfected with EV or HA-PIN1 expression construct. Forty-eight hours after
transfection, cells were either mock-treated or treated with CPT (1mM) for 1 h. Whole-cell lysates were analysed by immunoblotting using the indicated
antibodies. SE and LE denote short and long exposures of the same membrane. Asterisks indicate hyperphosphorylated forms of CtIP and RPA2,
respectively.
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upon DNA damage in late S and G2 phases of the cell cycle28.
We now conclude that PIN1 and CUL3-KLHL15 collaborate in
ﬁne adjusting CtIP protein stability to attenuate DNA-end
resection activity whenever NHEJ is the preferred mode of DSB
repair. Interestingly, a similar mechanism has been described for
PML degradation, which, in response to hypoxia, gets ﬁrst
isomerized by PIN1 and then ubiquitinated by the CUL3-
KLHL20 E3 ubiquitin ligase55. Clearly, further investigations
are required to elucidate how, at the molecular level,
isomerization-induced conformational changes in CtIP
stimulate its ubiquitination by CUL3-KLHL15 interaction.
Moreover, it also remains to be determined under which
physiological conditions CUL3-KLHL15 primes CtIP for
degradation in otherwise unperturbed cells. So far, studies on
Keap1 and KLHL20 revealed a possible mode for regulating
ubiquitination, which occurs at the level of the CUL3
adaptor rather than at the level of the substrate. CUL3-Keap1
constitutively targets Nrf2 until oxidative stress modiﬁes several
redox-sensitive cysteine residues of Keap1 interfering with the
E3-ligase activity56,57. Similarly, DAPK is constitutively degraded
by CUL3-KLHL20, until stress-induced interferon production
causes sequestering of KLHL20 into PML nuclear bodies and thus
away from its substrate58. In analogy to that, one could envision
that KLHL15 controls the basal protein level of CtIP to keep
DNA-end resection in check until certain stimuli modulate
CUL3-KLHL15 ubiquitin ligase activity to either accelerate or
delay CtIP protein turnover, thereby guiding DSB repair towards
either NHEJ or HR. Furthermore, we observed that KLHL15 is
predominantly chromatin-bound, suggesting that it may only
target CtIP for degradation in genomic loci where error-prone
repair by NHEJ is not detrimental to the cell. On the other hand,
KLHL15 may be absent from transcriptionally active chromatin
to allow DNA-end resection and HR59.
We also anticipate that KLHL15 function may be regulated at
multiple levels, including gene expression and subcellular
localization, as previously reported for KLHL20 (ref. 60). Along
this line, KLHL15 mRNA levels were reported to be highest in
lung, muscle and spleen, suggesting tissue-speciﬁc regulation of
KLHL15 expression44. Interestingly, publicly available gene
expression databases, such as MediSapiens, indicate highest
KLHL15 expression levels predominantly in hematopoietic
stem cells and in all four main types of leukemia
(http://ist.medisapiens.com/#ENSG00000174010). Notably, the
role for CtIP ubiquitination by KLHL15 in the regulation of
DSB repair was most likely acquired later during evolution, as
both KLHL15 as well as the KLHL15-binding motif in CtIP (FRY)
are highly conserved in vertebrates but missing in yeast and
worms.
Based on our data and the study of Oberg et al.44 on KLHL15-
dependent degradation of PP2A/B’-beta, we further hypothesize
that the FRY tripeptide sequence may constitute a consensus
KLHL15-Kelch domain interaction motif. In analogy to this, the
CUL3 adaptor Keap1 recognizes its substrates including NRF2
and PALB2 via a conserved E(S/T)GE motif61–63. Moreover, we
demonstrate that a CtIP-Y842F mutant is proﬁcient in being
targeted for degradation by KLHL15, excluding the possibility
that Y842 phosphorylation is a prerequisite for KLHL15 binding.
Nevertheless, phosphorylation of Y842 may negatively interfere
with CtIP-KLHL15 interaction. Consistent with this hypothesis,
inhibition of substrate recruitment to CRL3s by phosphorylation
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Figure 9 | CtIP ubiquitination by CUL3-KLHL15 promotes CtIP proteasomal degradation to ﬁne-tune DNA-end resection and DSB repair pathway
choice. Schematic model depicting the molecular architecture of the CUL3-KLHL15 E3 ubiquitin ligase complex and the functional consequences of
KLHL15-mediated CtIP protein turnover in controlling the balance between NHEJ and HR in normal KLHL15-expressing cells (upper part) and under
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has been previously reported19. For instance, NRF2 threonine
phosphorylation of the aforementioned ETGE motif disrupts its
interaction with Keap1 (ref. 26). It did also not escape our notice
that the KLHL15-binding motif is in immediate proximity to an
’RHR’ motif recently shown to be important for S. pombe Ctp1
binding to DNA in vitro38. However, based on the fact that the
’FRY motif’ is not conserved in yeast and considering that,
according to our data, CtIP-R839A is still degraded by KLHL15,
we think it is reasonable to conclude that CtIP ubiquitination by
KLHL15 (mediated through the ’FRY motif’) and CtIP binding to
DNA (mediated through the ’RHR motif’) are mutually exclusive
events in the regulation of DNA-end resection.
Lastly, our ﬁndings may have important therapeutic implica-
tions for some cancer types displaying KLHL15 overexpression.
For example, high KLHL15 protein levels may render cancer cells
hypersensitive to DNA topoisomerase inhibitors. Likewise,
mutations of KLHL15 may lead to aberrant activation of
DNA-end resection and HR-mediated DSB repair, which in turn
could again provide the opportunity to design more effective
personalized therapeutic strategies. In this respect, over 90
cancer-associated somatic mutations of KLHL15 are currently
recorded in the Catalogue of Somatic Mutations in Cancer
(COSMIC) database (www.cancer.sanger.ac.uk), but their
molecular effects on cancer pathogenesis require further
investigations.
Methods
Cell culture. U2OS and HEK293T cells (Invitrogen, Life Technologies) were
grown in DMEM supplemented with 10% FCS, 100Uml 1 penicillin, and
100mgml 1 streptomycin. U2OS Flp-In T-REx (a kind gift from Daniel Durocher,
University of Toronto) and HEK293 Flp-In T-Rex (Invitrogen, Life Technologies)
cells were maintained in medium supplemented with 10 mgml 1 blasticidin and
300mgml 1 zeocin. The Flp-In T-REx system (Invitrogen Life Technologies) was
used to generate cell lines stably expressing different siRNA-resistant GFP-CtIP or
GFP-KLHL15 constructs under the control of a doxycycline-inducible promoter. In
brief, expression vectors pcDNA5/FRT/TO-GFP-CtIP or pcDNA5/FRT/TO-GFP-
KLHL15 and the Flp recombinase expression plasmid, pOG44, were mixed in a 1:9
ratio and transfected into U2OS Flp-In T-REx cells (a kind gift of Daniel Durocher,
University of Toronto) using FuGENE6 Tranfection Reagent (Promega). 24 h later,
cells were plated at different dilutions and 48 h post-transfection the medium was
supplemented with 250mgml 1 hygromycin B and 12.5 mgml 1 blasticidin S. The
medium was replaced every 2–3 days and cells were selected for approximately
14 days. Resistant colonies were picked and single-cell clones analysed for GFP
expression by immunoblotting and immunoﬂuorescence microscopy. The
CtIP-Y842A mutation in stable U2OS cells was further veriﬁed by genomic
sequencing. HEK293Cas9/wt and HEK293Cas9/KLHL15D cell lines were generated as
described previously31. In brief, HEK293/Flp-In cells inducibly expressing
Cas9-FLAG (HEK293Cas9) were transfected with a plasmid (DU46129,
U6_gRNA_empty vector) encoding a short guide RNA (sgRNA) targeting KLHL15
or the empty vector as control. Eight hours after transfection Cas9-FLAG
expression was induced with Dox (1 mgml 1). Forty-eight hours after transfection,
cells were seeded at a high dilution to generate single-cell-derived clones. Lysates
from HEK293Cas9/KLHL15D cell clones were screened for the loss of KLHL15
expression by western blotting. Finally, the targeted genomic region was ampliﬁed
by PCR using the following primers (forward, 50-TGGTGAAGTTCTGCTGC
TCT-30; reverse, 50-GCCTAGACATGAGTGGCACA-30) and analysed for the
presence of insertion and deletion (Indel) mutations by deep-sequencing. All cell
lines were conﬁrmed to be free of mycoplasma contamination.
Cell irradiation. IR was given using a Faxitron X-ray machine. Laser micro-
irradiation was performed as described previously64. Brieﬂy, 24 h before irradiation,
cells were grown in medium supplemented with 10 mM BrdU. Cells were
microirradiated using a MMI CELLCUT system containing a UVA laser of 355 nm
(Molecular Machines and Industries, Zurich, Switzerland). The laser intensity was
set to 50% energy output and each cell was exposed to the laser beam foro300ms.
Chemicals and peptides. MG-132, cycloheximide and CPT were purchased from
Sigma. MLN-4924 was purchased from Active Biochem. The biotinylated 15-mer
peptide encompassing CtIP amino acid residues 830–844 was purchased from
Bachem AG (Bubendorf, Switzerland) and dissolved in water at 1mgml 1.
Vectors. GFP or FLAG-tagged CtIP expression constructs and pGEX-4T1
plasmids for bacterial expression of CtIP fragments were described previously8.
The pCMV6-myc-FLAG-KLHL15 expression plasmid was obtained from
Origene (NM_030624 Human cDNA True ORF Clone, Origene). The
pcDNA3.1-6xHis-Ubiquitin as well as the pcDNA3.1-HA-KLHL22 expression
plasmid65 were a gift from Matthias Peter (ETH Zurich, Switzerland). All CtIP and
KLHL15 mutations were introduced by site-directed mutagenesis using Expand
Long Template PCR System (Roche) and conﬁrmed by sequencing. Plasmids were
transfected either by using the standard calcium phosphate method or FuGENE 6
(Promega) according to manufacturer’s instructions.
Antibodies. A complete list of all primary antibodies (with manufacturers,
catalogue numbers and applications) used throughout this study can be found in
Supplementary Table 1. Secondary HRP-conjugated anti-mouse and anti-rabbit
antibodies were from GE- Healthcare and the HRP-conjugated anti-goat antibody
was from Santa Cruz Biotech. Alexa Fluor-488, -594, and -647-conjugated
secondary antibodies were purchased from Invitrogen. Rabbit polyclonal
antibodies speciﬁc for KLHL15 were generated as follows. Human KLHL15 cDNA
corresponding to amino acids 300–604 was cloned into pET30a (Novagen) vector
for expression in Escherichia coli. The recombinant His-tagged KLHL15 fragment
was puriﬁed using Ni-NTA (Qiagen) following the manufacturer’s instructions and
subsequently used to immunize rabbits. After ﬁve immunizations, serum was
obtained and puriﬁed against the recombinant antigen. For that, 100–200 mg
of the KLHL15 antigen was loaded onto SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) and then transferred to a nitrocellulose membrane before staining
with Ponceau S. The part of the membrane containing the antigen was cut out,
blocked with 2% BSA in TBS-T for 1 h and then incubated with the serum
overnight at 4 C. Bound antibodies were eluted with 0.15M glycine-HCl, pH 2.3.
1M Tris-HCl, pH 8.8, was immediately added to neutralize the pH of the antibody
solution to pH 7.5.
siRNA. Transfection of siRNA oligos was done using Lipofectamine RNAiMAX
(Invitrogen). CNTL, CtIP, CUL3 and KLHL15#2 were purchased from Microsynth
and the sequences (50 to 30) were as follows: CNTL (luciferase; 50-CGUACGCG
GAAUACUUCGA-30)8, CtIP (50-GCUAAAACAGGAACGAAUC-30)8, CUL3
(50-CAACACTTGGCAAGGAGAC-30)66 and KLHL15#2 (50-GCGTAAACATCG
AGGGAG-30). SMARTpool ON-TARGETplus Human KLHL15 siRNA
(KLHL15#1) was purchased from Dharmacon. Trisilencer-27 human KLHL15
siRNA B targeting the 30-untranslated region of KLHL15 (KLHL15#3) was
purchased from OriGene.
Double afﬁnity puriﬁcation coupled to mass spectrometry. The procedure was
performed as described previously with some minor modiﬁcations67. Brieﬂy,
CtIP cDNA was subcloned into the pN-TGSH plasmid (Dualsystems Biotech AG,
Schlieren, Switzerland) for tetracycline (Tet)-inducible expression of
strep-hemagglutinin (SH)-tagged CtIP bait protein. An isogenic cell line was
generated using Flp-recombinase-mediated recombination through single FRT
sites present in the pN-TGSH-CtIP expression construct and the genome of Flp-In
HEK293 cells (Invitrogen) stably expressing the Tet repressor. After transfection,
HEK293SH-CtIP cells were selected on hygromycin for 2 weeks, tested for
Tet-inducible expression of SH-CtIP and used for subsequent double afﬁnity
puriﬁcation. The afﬁnity-puriﬁed proteins were digested into peptides and the
peptide mixture was separated on a C18 HPLC column. Mass spectrometry
analysis (direct liquid chromatography-tandem mass spectrometry) was performed
using an LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientiﬁc). Peptides
of only three proteins, CtIP (Bait), KLHL15 and Cullin-3, were identiﬁed in both
biological replicates (see Fig. 1a).
RNA extraction and real-time quantitative RT–PCR. Total RNA was extracted
using the GenElute Mammalian Total RNA Miniprep Kit (Sigma) according to the
manufacturer’s protocol. Reverse transcription of mRNA was carried out using the
Transcriptor First Strand Synthesis kit (Roche). KLHL15 mRNA expression
analysis was performed using LightCycler 480 SYBR Green I Master (Roche)
and the following primers: KLHL15 (Fw: 50-ATCATTCAGAATATCCGGTTTT
GCT-30 , Rw: 5’-TTCAATGCTTGGTCAACTTCGTAA-3’) and PBGD (Fw: 50-CA
ACGGCGGAAGAAAACAG-30 , Rw: 50-TCTCTCCAATCTTAGAGAGTG-30).
PBGD expression served as an internal control for quantitative RT-PCR assays and
was used to normalize KLHL15 expression levels.
Puriﬁcation of recombinant human KLHL15. The KLHL15 gene was ampliﬁed
from pCMV6-KLHL15 vector using PCR and subcloned into the pFB-MBP-fusion
plasmid (a kind gift of Petr Cejka). The virus was produced using a Bac-to-Bac
system (Invitrogen) according to manufacturers’ recommendations. MBP-KLHL15
was puriﬁed as described previously68. Brieﬂy, pellets of 3.2 liters of cultured Sf9
cells expressing MBP-KLHL15 were resuspended in three pellet volumes of lysis
buffer (50mM Tris-HCl, pH 7.5, 1mM DTT, 1mM EDTA, cOmplete EDTA-free
Protease Inhibitor Cocktail tablets (Roche), 1mM PMSF and 30 mgml 1
leupeptin). Cells were incubated for 15min with gentle agitation, and then two
pellet volumes of ice-cold 50% glycerol were added to the sample. Next, 5M NaCl
(6.5% of the total solution volume) was added dropwise to the sample, and the
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solution was incubated for 30min with gentle agitation. The soluble extract was
obtained by pelleting the insoluble material at 20,000g for 30min. The soluble
cleared extract was bound to pre-equilibrated amylose resin (New England
Biolabs). The resin was extensively washed with wash buffer (50mM Tris-HCl,
pH 7.5, 5mM b-mercaptoethanol, 250mM NaCl, 10% glycerol, 1mM PMSF,
10 ugml 1 leupeptin). The resin was incubated for an additional 10min in wash
buffer supplemented with 2mM ATP and 10mM MgCl2 to remove some
contaminating chaperones. MBP-KLHL15 was eluted with elution buffer (50mM
Tris-HCl, pH 7.5, 5mM b-mercaptoethanol, 250mM NaCl, 10% glycerol, 1mM
PMSF, 10 ugml 1 leupeptin and 10mM maltose). Next, the maltose-binding
protein (MBP) was cleaved by PreScission protease and the sample was applied on
Ni-NTA resin (Qiagen). The resin was washed with washing buffer containing
40mM imidazole and eluted in the same buffer containing 400mM imidazole.
Pooled fractions were dialysed against dialysis buffer (50mM Tris-HCl, pH 7.5,
5mM b-mercaptoethanol, 300mM NaCl, 10% glycerol, 0.5mM PMSF). The
sample was aliquoted, frozen in liquid nitrogen and stored at  80 C.
CellTiter-Blue Cell Viability assay. U2OS Flp-In T-REx cells stably expressing
doxycycline (Dox)-inducible siRNA-resistant forms of GFP-CtIP or GFP-KLHL15
were transfected with the indicated siRNA oligos. Twenty-four hours post-
transfection, cells were seeded in triplicates at a density of 500 cells/well in 96-well
plates in medium supplemented with Dox (1mgml 1). 24 h later, cells were
continuously treated with indicated doses of camptothecin and grown for 4 days at
37 C. To measure cell viability, CellTiter-Blue reagent (Promega) was added on
the last day, cells were incubated at 37 C for 4 h and ﬂuorescence was measured at
560/590 nm.
Colony-formation assay. U2OS Flp-In T-REx cells were induced to express
GFP-KLHL15-wt or GFP-KLHL15-Y552A using Dox (1 mM). Cells were either
mock-treated (DMSO) or treated with the indicated doses of CPT 24 h after
Dox-induction. HEK293Cas9 wt or KLHL15D cells were seeded on poly-lysine
coated plates and 24 h later irradiated with 1, 2 or 4Gy. Cells were cultured for
10 days at 37 C. Colonies were stained with a crystal violet/ethanol (0.5%/20%)
solution and counted.
Immunoblotting and triton extraction. If not speciﬁed otherwise, cell extracts
were prepared in Laemmli buffer (4% SDS, 20% glycerol, 120mM Tris-HCl pH
6.8). Proteins were resolved by SDS–PAGE and transferred to nitrocellulose.
Immunoblots were performed with appropriate antibodies and proteins visualized
using the Advansta WesternBright ECL reagent and the VilberLourmat Fusion
Solo S imaging system. Isolation of Triton-insoluble (chromatin-enriched)
fractions was performed as previously described39. Brieﬂy, cells were rinsed twice in
cold PBS, incubated for 5min on ice in pre-extraction buffer (25mM HEPES pH
7.4, 50mM NaCl, 1mM EDTA, 3mM MgCl2, 300mM sucrose, 0.5% Triton X-100
and protease inhibitors). After buffer removal, adherent cellular material was
harvested by scraping the cells into Laemmli buffer. The chromatin-enriched
fraction was then heat denatured, sonicated and analysed by immunoblotting.
Uncropped immunblots are shown in Supplementary Fig. 9.
Pull-down assays. HeLa nuclear extracts were purchased from CilBiotech (Mons,
Belgium). For all pull-down assays, cells were lysed in NP-40 extraction buffer
(50mM Tris-HCl, pH 7.5, 120mM NaCl, 1mM EDTA, 6mM EGTA, 15mM
sodium pyrophosphate and 1% NP-40 supplemented with phosphatase inhibitors
(20mM NaF, 1mM sodium orthovanadate) and protease inhibitors (1mM
benzamidine and 0.1mM PMSF) and clariﬁed by centrifugation. For GST
pull-down assays, GST fusion plasmids were grown in BL21 RIL (CodonPlus)
E. coli (Stratagene) and recombinant proteins were expressed by incubating the
bacteria for 24 h at 16 C after the addition of 100 mM IPTG. After centrifugation,
the bacterial pellet was resuspended in cold PBS, supplemented with 1% Triton
X-100 and protease inhibitors (1mM PMSF, 1mM benzamidine, and Roche
protease inhibitor cocktail). After sonication and centrifugation, GST-tagged
proteins were puriﬁed from soluble extracts using Glutathione Sepharose 4 Fast
Flow beads (GE Healthcare). GST fusion proteins bound to glutathione beads were
mixed with 1mg of HeLa nuclear extract or 1mg of HEK293 cells extracts and
incubated for 1 h at 4 C in 1ml of PBS-1%Triton. Beads were then washed three
times with NTEN300 buffer (0.5% NP-40, 0.1mM EDTA, 20mM Tris-HCl pH 7.4
and 300mM NaCl) and once with TEN100 (20mM Tris-HCl pH 7.4, 0.1mM
EDTA and 100mM NaCl) buffer. Recovered complexes were boiled in SDS sample
buffer and analysed by SDS–PAGE followed by immunoblotting. For MBP
pull-down assays, Sf9 soluble cleared extract expressing MBP-KLHL15-His were
incubated with amylose resin (New England Biolabs) and washed four times with
NTEN300 buffer (0.5% NP-40, 0.1mM EDTA, 20mM Tris-HCl pH 7.4, 300mM
NaCl) and once with TEN100 buffer (20mM Tris-HCl pH 7.4, 0.1mM EDTA and
100mM NaCl). MBP fusion proteins bound to amylose beads were mixed with
1mg of HEK293T lysates overexpressing GFP-CtIP and incubated for 1 h at 4 C.
Beads were then washed four times with NTEN300 buffer and once with TEN100
buffer, complexes were boiled in SDS sample buffer and analysed by SDS–PAGE
followed by immunoblotting. For peptide pull-down assays, biotinylated CtIP
peptides were incubated with Dynabeads streptavidin resin (Qiagen) and washed
four times with 1%Triton-PBS. Beads were then mixed with 2.5mg of U2OS or
1mg of HEK293T lysates and incubated for 1 h at 4 C. Beads were then washed
four times with NP-40 extraction buffer, complexes were boiled in SDS sample
buffer and analysed by SDS–PAGE followed by immunoblotting.
Co-immunoprecipitation. For FLAG and HA co-IP assays, cells were lysed in
NP-40 extraction buffer, sonicated and clariﬁed by centrifugation. A total of
1–3mg of lysates were incubated with anti-FLAG M2 or anti-HA afﬁnity resin
(Sigma) for 2 h or overnight at 4 C. Beads were then washed four times with
1xTNE-T (50mM Tris-HCl, pH 7.5, 140mM NaCl, 5mM EDTA and 1%Triton)
and once with 1TNE (50mM Tris-HCl, pH 7.5, 140mM NaCl and 5mM
EDTA), complexes were boiled in SDS sample buffer and analysed by
SDS–PAGE followed by immunoblotting. For GFP co-IP assays, cells were lysed in
GFP-IP buffer (100mM NaCl, 0.2% NP-40, 1mM MgCl2, 10% glycerol, 5mM
NaF, 50mM Tris-HCl, pH 7.5) supplemented with phosphatase inhibitors
(20mM NaF, 1mM sodium orthovanadate) and with protease inhibitors (1mM
benzamidine and 0.1mM PMSF) and incubated with Benzonase (Novagen) for at
least 30min at 4 C. After Benzonase digestion, the NaCl and ETA concentrations
were adjusted to 200 and 2mM, respectively, and lysates cleared by centrifugation.
Four milligram of lysates were incubated with GFP-Trap agarose beads
(ChromoTek) previously blocked with 5% BSA in GFP-IP buffer (with 200mM
NaCl and 2mM EDTA ﬁnal concentrations) for 1 h at 4 C. Beads were then
washed ﬁve times with GFP-IP buffer (with 200mM NaCl and 2mM EDTA ﬁnal
concentrations), complexes were boiled in SDS sample buffer and analysed by
SDS–PAGE followed by immunoblotting.
In vivo ubiquitination assay. Stable HEK293 Flp-In T-REx GFP-CtIP cells were
transfected with siRNA oligos (20–40 nM). Forty-eight hours later, cells were
transfected with His-ubiquitin and GFP-expression was simultaneously induced
with 1 mgml 1 Dox. Eight hours after induction a second transfection with siRNA
oligos was performed. Alternatively, HEK293T cells were cotransfected with
His-Ubiquitin and GFP-CtIP expression constructs. Twenty-four hours after
induction or transfection of GFP-CtIP, respectively, cells were treated for 4–6 h
with 20mM MG-132 and then washed and scraped in 500ml of ice-cold PBS. 2% of
the cell suspension was used for direct immunoblot analysis. The remaining cells
were lysed in Buffer A (6M guanidine–HCl, 0.1M Na2HPO4/NaH2PO4 pH 8.0,
10mM imidazole), and lysates were incubated with Ni-NTA agarose beads for 3 h
under rotation at room temperature. The beads were washed two times with Buffer
A, two times with Buffer A/TI (one volume Buffer A: three volume Buffer TI
(25mM Tris-HCl pH 6.8, and 20mM imidazole)), and three times with Buffer TI.
Proteins were eluted from the beads by boiling in 2 SDS sample buffer
supplemented with 250mM imidazole and analysed by immunoblotting.
In vitro ubiquitination assay. Recombinant E2 enzymes (UbcH5b and Cdc34)
were puriﬁed as described before. In brief, UbchH5b and Cdc34 full-length
constructs were expressed as GST-fusions in BL21 E. coli and puriﬁed over a
5ml GST HiTrap column (GE Healthcare) and a Superdex75 size exclusion
chromatography column (GE Healthcare) using standard protocols69,70.
Neddylated CUL3 in complex with RBX1 was produced as described before. In
brief, full-length CUL3, tagged with an N-terminal PreScission-cleavable StrepII2x
tag, and RBX1 were cloned into a pFBDM multibac transfer vector. Following the
generation of recombinant baculoviruses, CUL3/RBX1 complexes were expressed
and puriﬁed from high ﬁve insect cells following standard Strep-Tactin afﬁnity,
ion exchange and Superdex200 size exclusion chromatography procedures.
Neddylation of CUL3/RBX1 was performed by incubating 10 mM CUL3/RBX1,
0.5 mM APPB1/UBA3 (NEDD8-speciﬁc activating enzyme E1), 1 mM UBC12
(NEDD8-speciﬁc conjugating enzyme E2) and 20 mM NEDD8 at room
temperature for 10min in buffer containing 100mM Tris-HCl pH 7.6, 100mM
NaCl, 2.5mM MgCl2 and 150mM ATP. The neddylated CUL3-N8/RBX1 was
subsequently puriﬁed by Strep-Tactin afﬁnity chromatography with the untagged
neddylation reagents retained in the ﬂow through30. Full-length wild-type human
KLHL21 was cloned into a pGEX-5 expression vector and expressed in BL21
E. coli. The cells were lysed by sonication in the presence of protease inhibitors and
lysozyme. The soluble supernatant was bound to a 5ml GST HiTrap column
(GE Healthcare) with a ﬂow rate of 1mlmin 1. The column was washed with 20
column volumes (CV) of washing buffer and eluted with ﬁve CV of washing buffer
supplemented with 10mM reduced L-gluthatione (AppliChem). The eluted
GST-KLHL21 was incubated in a 1:50 molar ratio with GST-tagged PreScisscion
protease at 4 C and the buffer exchanged by dialysis into 150mM NaCl, 20mM
HEPES pH 7.6, 10% glycerol, 2mM DTT. To remove cleaved GST and
GST-PreScission proteins, the sample was run through a GST HiTrap column a
second time, and puriﬁed KLHL21 was collected in the ﬂow-through. The CtIP
substrate was puriﬁed as follows: NP-40 lysates of HEK293T cells transfected with
FLAG-CtIP were incubated with anti-FLAG M2 beads (Sigma) for 1 h at 4 C. The
resin was washed four times with NTEN500 buffer (0.5% NP-40, 0.1mM EDTA,
20mM Tris-HCl, pH 7.4, 500mM NaCl) and once with TEN100 buffer.
FLAG-CtIP was eluted with 3xFLAG peptides (Sigma) in TBS. If not indicated
otherwise, ubiquitination reactions were performed at 37 C for 90min with
400 nM of FLAG-CtIP, 250 nM of KLHL15 or KLHL21, 200 nM of neddylated
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CUL3/RBX1, 250 nM UbE1 (Lifesensor), 500 nM UbcH5b or 2 mM Cdc34 and
75mM ubiquitin wild-type or mutants (Bostonbiochem). The reaction was stopped
by the addition of SDS sample buffer supplemented with 20mM DTT and boiling
for 5min at 95 C and analysed by SDS–PAGE followed by immunoblotting on
PVDF membrane (Amersham).
Immunoﬂuorescence microscopy. U2OS cells grown on coverslips were ﬁxed in
4% formaldehyde (w/v) in PBS for 15min and permeabilized with Triton X-100
(0.1% in PBS) for 5min at room temperature. After incubation with indicated
primary and appropriate Alexa Fluor-488, -594 and -647 conjugated secondary
antibodies (1:1,000) (Life Technologies) for 30min, coverslips were mounted with
Vectrashield (Vector Laboratories) containing DAPI and sealed. Images were
acquired on a Leica DMRB ﬂuorescence microscope.
Flow cytometry-based resection assay. U2OS Flp-In T-REx cells stably
expressing Dox-inducible siRNA-resistant forms of GFP-CtIP were transfected
with CtIP siRNA. 24 h post-transfection, Dox (1 mgml 1) and BrdU (30 mM)
were added to the cells. Forty-eight hours post-transfection, cells were either
mock-treated or treated with CPT (1 mM). Alternatively, U2OS Flp-In T-REx cells
stably expressing Dox-inducible GFP-KLHL15 were induced with Dox (1 mgml 1)
and after 24 h treated with CPT (1mM). Alternatively, HEK293Cas9 cells were
directly treated with CPT (1mM). 1 h following CPT treatment, all cells were
collected, pre-extracted with Triton-X100 (0.3% in PBS) for 15min on ice and ﬁxed
with 4% formaldehyde for 10min at room temperature. Cells were then incubated
with antibodies against RPA2 or BrdU for 1 h at room temperature, stained with
Alexa-647 conjugated secondary antibodies (1:250) for 30min at room temperature
and counterstained with DAPI/RNase. Samples were analysed by ﬂow cytometry
on a CyAn ADP 9 (Dako). Data analysis was performed using FlowJo X software
(Tree Star).
GFP reporter assays. DSB repair efﬁciency by HR or NHEJ was measured in
DR-GFP or EJ5-GFP HEK293 cell lines as described previously28. Brieﬂy, 0.6 106
cells were plated in poly-L-lysine-coated six-well plates and transfected with siRNA
oligos (20–40 nM). The next day, 0.22 106 cells were reseeded in 12-well plates.
Forty-eight hours after siRNA transfection, cells were either mock-transfected or
transfected with 0.6 mg of the I-SceI expression plasmid (pCBASce) mixed with
0.2 mg of the indicated siRNA-resistant FLAG-CtIP (pcDNA3) constructs. Four
hours after plasmid transfection, the medium was replaced and a second
transfection with siRNA oligos was performed. Alternatively, GFP reporter assays
upon siRNA-mediated knockdown conditions only were performed like described
above except that the cells were either mock-transfected or transfected with 0.6 mg
of the I-SceI expression plasmid. Alternatively, 0.22 106 cells were seeded in
12-well plates and 24 h later either mock-transfected or transfected with 0.6 mg
I-SceI expression plasmid mixed with 0.2 mg of the indicated FLAG-KLHL15
constructs (pCMV6). Forty-eight hours after I-SceI transfection, cells were
analysed for GFP expression by ﬂow cytometry on a CyAn ADP 9 (Dako).
Data availability. The authors declare that all remaining data supporting the
ﬁndings of this study are contained within the article and its Supplementary
Information Files or available from the author upon request.
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